» Articles » PMID: 29850208

Phenotypic Variation in a Four-Generation Family with Aniridia Carrying a Novel Mutation

Overview
Journal J Ophthalmol
Publisher Wiley
Specialty Ophthalmology
Date 2018 Jun 1
PMID 29850208
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Aniridia is a congenital disease that affects almost all eye structures and is primarily caused by loss-of-function mutations in the gene. The degree of vision loss in aniridia varies and is dependent on the extent of foveal, iris, and optic nerve hypoplasia and the presence of glaucoma, cataracts, and corneal opacification. Here, we describe a 4-generation family in which 7 individuals across 2 generations carry a novel disease-causing frameshift mutation (NM_000280.4(PAX6):c.565TC>T) in This mutation results in an early stop codon in exon 8, which is predicted to cause nonsense-mediated decay of the truncated mRNA and a functionally null allele. Family members with aniridia showed differences in multiple eye phenotypes including iris and optic nerve hypoplasia, congenital and acquired corneal opacification, glaucoma, and strabismus. Visual acuity ranged from 20/100 to less than 20/800. Patients who required surgical intervention for glaucoma or corneal opacification had worse visual outcomes. Our results show that family members carrying a novel frameshift mutation have variable expressivity, leading to different ocular comorbidities and visual outcomes.

Citing Articles

Patient-derived cornea organoid model to study metabolomic characterization of rare disease: aniridia-associated keratopathy.

Koc A, Sari V, Kocak G, Recber T, Nemutlu E, Aberdam D BMC Ophthalmol. 2025; 25(1):14.

PMID: 39794714 PMC: 11724546. DOI: 10.1186/s12886-024-03831-w.


The Systemic Genotype-Phenotype Characterization of PAX6-Related Eye Disease in 164 Chinese Families.

Jiang Y, Yi Z, Zheng Y, Ouyang J, Guo D, Li S Invest Ophthalmol Vis Sci. 2024; 65(10):46.

PMID: 39212610 PMC: 11364179. DOI: 10.1167/iovs.65.10.46.


Genetic changes and testing associated with childhood glaucoma: A systematic review.

Kumar A, Han Y, Oatts J PLoS One. 2024; 19(2):e0298883.

PMID: 38386645 PMC: 10883561. DOI: 10.1371/journal.pone.0298883.


Clinical outcomes and visual prognostic factors in congenital aniridia.

Jacobson A, Mian S, Bohnsack B BMC Ophthalmol. 2022; 22(1):235.

PMID: 35614435 PMC: 9131660. DOI: 10.1186/s12886-022-02460-5.


Glaucoma Syndromes: Insights into Glaucoma Genetics and Pathogenesis from Monogenic Syndromic Disorders.

Balikov D, Jacobson A, Prasov L Genes (Basel). 2021; 12(9).

PMID: 34573386 PMC: 8471311. DOI: 10.3390/genes12091403.


References
1.
Grindley J, Davidson D, Hill R . The role of Pax-6 in eye and nasal development. Development. 1995; 121(5):1433-42. DOI: 10.1242/dev.121.5.1433. View

2.
Lee H, Khan R, OKeefe M . Aniridia: current pathology and management. Acta Ophthalmol. 2008; 86(7):708-15. DOI: 10.1111/j.1755-3768.2008.01427.x. View

3.
Carriere C, Plaza S, Caboche J, Dozier C, Bailly M, MARTIN P . Nuclear localization signals, DNA binding, and transactivation properties of quail Pax-6 (Pax-QNR) isoforms. Cell Growth Differ. 1995; 6(12):1531-40. View

4.
Cheng F, Song W, Kang Y, Yu S, Yuan H . A 556 kb deletion in the downstream region of the PAX6 gene causes familial aniridia and other eye anomalies in a Chinese family. Mol Vis. 2011; 17:448-55. PMC: 3038207. View

5.
DElia A, Pellizzari L, Fabbro D, Pianta A, Divizia M, Rinaldi R . A deletion 3' to the PAX6 gene in familial aniridia cases. Mol Vis. 2007; 13:1245-50. View